Why Axovant Is Getting Absolutely Crushed
Axovant Sciences shares cratered early on Tuesday after the firm provided an update from its late-stage Alzheimer’s trial.
All Work
Chris Lange
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a down day for the U.S. broad markets with the Nasdaq seeing one of its worst days on the year. Despite markets being down crude oil rocketed up and brought up the…
Why Deutsche Bank Is Picking GM Over Tesla
General Motors shares made a handy gain on Monday following an incredible upgrade Deutsche Bank.
How Genuine Parts Is Breaking Into Europe
Genuine Parts shares made a solid gain to kick off the week, pushing back to even on the year. What spurred this turnaround?
Why Facebook Is Ditching Its Stock Reclassification Plan
Facebook shares took a step back on Monday following the announcement that the social media giant would not go through with its controversial stock split plan.
Can Target Afford a $15 Minimum Wage?
Target is setting a new precedent among most major retailers, and thousands of Target employees are going to see a nice addition on their checks.
Switch Announces Potential Pricing for IPO
Data center operator Switch expects to price more than 31 million shares for an initial public offering valued up to about $575 million.
Nike, Micron and More Earnings Coming This Week
24/7 Wall St. has put together a preview of Nike, Micron Technology and a few other major companies scheduled to report their quarterly results this coming week.
The Top 2 Tech Analyst Calls for the Rest of 2017
A couple of analysts released calls this past week about where these two chip stocks stand to run. Merrill Lynch weighed in on Nvidia and Jefferies focused on AMD.
Friday’s Biggest Winners and Losers in the S&P 500
The S&P 500 closed up 0.05% at 2,501.97. The DJIA closed down 0.05% at 22,347.32 and the Nasdaq finished the day up 0.07% at 6,426.92.
Another Data Exposure Uncovered at Verizon
It came to light on Friday that Security researchers had discovered another data exposure at Verizon Communications Inc. (NYSE: VZ). Security researchers at Kromtech Security Research center found the exposure in an unprotected Amazon…
Tale of the Tape: Why McDonald’s Is a Top Stock in 2017
McDonald’s has been at the forefront of the Dow Jones Industrial Average index as one of its top five performing components this year,
Is This the Death of Versartis?
Versartis shares absolutely cratered on Friday after the firm announced results from its late-stage Velocity clinical trial of somavaratan in pediatric growth hormone deficiency.
Is It Time for a Turnaround at Finish Line?
After Finish Line reported its fiscal second-quarter financial results before the markets opened on Friday, shares rose handily.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a down day for the U.S. broad markets with all averages pulling back from their all-time highs. Crude oil didn’t do too much on the day and oil & gas stocks had…
FDA Crashes Down on Intercept’s Deadly Drug
As we have said before, updates from the FDA have the potential to make or break a company. In this case it seems like a mild setback, but further complications could prove to be…
Why Jefferies Sees AMD Rising 40%
Some might think the run at AMD is over, or that shares might slow down after a rally like this, but one analyst is continuing to take a bullish stance on the stock.
Can Snap’s Newest Partner Stop Shares From Falling?
To say that this social media company’s shares are struggling might be an understatement. However with this new partnership Snap is looking to pull in some more ad revenue.
How Harry Potter Killed Scholastic Shares
Scholastic released its most recent quarterly results before the markets opened on Thursday. Looking at the numbers year over year, there is a huge disparity, and a reason behind it.
Can BioCryst Turn Itself Around With This FDA Approval?
BioCryst Pharmaceuticals has received an update from the FDA. This approval is very welcome as BioCryst has been underperforming the market so far this year.